PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of envhperEnvironmental Health PerspectivesBrowse ArticlesAbout EHPGeneral InformationAuthorsMediaProgramsPartnerships
 
Environ Health Perspect. 1982 February; 43: 9–19.
PMCID: PMC1568899
Research Article

Diseases associated with immunosuppression.

Abstract

Impairment of any of the major components of the immune system (T-cells, B-cells phagocytes, complement) may result in clinical immunodeficiency. Immune defects can arise from intrinsic or heritable defects of lymphoid elements, failure of normal cellular differentiation, viral infection or other acquired causes. Clinical impairment of immunity is expressed as a marked susceptibility to opportunistic and pathogenic organisms which are difficult to control and by an increased risk of malignancy, allergy and autoimmune disease. Certain immunodeficiency disorders are associated with aberrant immune regulation. The major types of immune deficiency are characterized by unique patterns of infections depending on the level at which the defect occurs and the pathogenic mechanisms of the parasite. The basic defects of representative primary and secondary immunodeficiencies are discussed in relation to observed immunologic consequences.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (1.8M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Horowitz SD, Hong R. The pathogenesis and treatment of immunodeficiency. Monogr Allergy. 1977;10:1–198. [PubMed]
  • Gathings WE, Lawton AR, Cooper MD. Immunofluorescent studies of the development of pre-B cells, B lymphocytes and immunoglobulin isotype diversity in humans. Eur J Immunol. 1977 Nov;7(11):804–810. [PubMed]
  • Kung PC, Goldstein G. Functional and developmental compartments of human T lymphocytes. Vox Sang. 1980 Sep;39(3):121–127. [PubMed]
  • Reinherz EL, Schlossman SF. Current concepts in immunology: Regulation of the immune response--inducer and suppressor T-lymphocyte subsets in human beings. N Engl J Med. 1980 Aug 14;303(7):370–373. [PubMed]
  • Reinherz EL, Kung PC, Goldstein G, Schlossman SF. A monoclonal antibody reactive with the human cytotoxic/suppressor T cell subset previously defined by a heteroantiserum termed TH2. J Immunol. 1980 Mar;124(3):1301–1307. [PubMed]
  • Cohen A, Hirschhorn R, Horowitz SD, Rubinstein A, Polmar SH, Hong R, Martin DW., Jr Deoxyadenosine triphosphate as a potentially toxic metabolite in adenosine deaminase deficiency. Proc Natl Acad Sci U S A. 1978 Jan;75(1):472–476. [PubMed]
  • Gelfand EW, Oliver JM, Schuurman RK, Matheson DS, Dosch HM. Abnormal lymphocyte capping in a patient with severe combined immunodeficiency disease. N Engl J Med. 1979 Dec 6;301(23):1245–1249. [PubMed]
  • Cohen A, Gudas LJ, Ammann AJ, Staal GE, Martin DW., Jr Deoxyguanosine triphosphate as a possible toxic metabolite in the immunodeficiency associated with purine nucleoside phosphorylase deficiency. J Clin Invest. 1978 May;61(5):1405–1409. [PMC free article] [PubMed]
  • Dosch HM, Percy ME, Gelfand EW. Functional differentiation of B lymphocytes in congenital agammaglobulinemia. I. Generation of hemolytic plaque-forming cells. J Immunol. 1977 Dec;119(6):1959–1964. [PubMed]
  • Hitzig WH, Dohmann U, Pluss HJ, Vischer D. Hereditary transcobalamin II deficiency: clinical findings in a new family. J Pediatr. 1974 Nov;85(5):622–628. [PubMed]
  • Siegal FP, Siegal M, Good RA. Suppression of B-cell differentiation by leukocytes from hypogammaglobulinemic patients. J Clin Invest. 1976 Jul;58(1):109–122. [PMC free article] [PubMed]
  • Fauci AS, Steinberg AD, Haynes BF, Whalen G. Immunoregulatory aberrations in systemic lupus erythematosus. J Immunol. 1978 Oct;121(4):1473–1479. [PubMed]
  • Reinherz EL, Geha R, Wohl ME, Morimoto C, Rosen FS, Schlossman SF. Immunodeficiency associated with loss of T4+ inducer T-cell function. N Engl J Med. 1981 Apr 2;304(14):811–816. [PubMed]
  • Reinherz EL, Parkman R, Rappeport J, Rosen FS, Schlossman SF. Aberrations of suppressor T cells in human graft-versus-host disease. N Engl J Med. 1979 May 10;300(19):1061–1068. [PubMed]
  • Iio A, Strober W, Broder S, Polmar SH. The metabolism of IgE in patients with immunodeficiency states and neoplastic conditions. J Clin Invest. 1977 May;59(5):743–755. [PMC free article] [PubMed]
  • FAHEY JL, SCOGGINS R, UTZ JP, SZWED CF. INFECTION, ANTIBODY RESPONSE AND GAMMA GLOBULIN COMPONENTS IN MULTIPLE MYELOMA AND MACROGLOBULINEMIA. Am J Med. 1963 Nov;35:698–707. [PubMed]
  • Barandum S, Morell A, Skvaril F, Keller H. immunoperturbation in paraproteinemia. Birth Defects Orig Artic Ser. 1975;11(1):95–98. [PubMed]
  • Twomey JJ. Infections complicating multiple myeloma and chronic lymphocytic leukemia. Arch Intern Med. 1973 Oct;132(4):562–565. [PubMed]
  • ZINNEMAN HH, HALL WH. Recurrent pneumonia in multiple myeloma and some observations on immunologic response. Ann Intern Med. 1954 Dec;41(6):1152–1163. [PubMed]
  • Broder S, Humphrey R, Durm M, Blackman M, Meade B, Goldman C, Strober W, Waldmann T. Impaired synthesis of polyclonal (non-paraprotein) immunoglobulins by circulating lymphocytes from patients with multiple myeloma Role of suppressor cells. N Engl J Med. 1975 Oct 30;293(18):887–892. [PubMed]
  • Casazza AR, Duvall CP, Carbone PP. Summary of infectious complications occurring in patients with Hodgkin's disease. Cancer Res. 1966 Jun;26(6):1290–1296. [PubMed]
  • Young RC, Corder MP, Haynes HA, DeVita VT. Delayed hypersensitivity in Hodgkin's disease. A study of 103 untreated patients. Am J Med. 1972 Jan;52(1):63–72. [PubMed]
  • Swan HT, Knowelden J. Prognosis in Hodgkin's disease related to the lymphocyte count. Br J Haematol. 1971 Sep;21(3):343–349. [PubMed]
  • Brown RS, Haynes HA, Foley HT, Godwin HA, Berard CW, Carbone PP. Hodgkin's disease. Immunologic, clinical, and histologic features of 50 untreated patients. Ann Intern Med. 1967 Aug;67(2):291–302. [PubMed]
  • Levy R, Kaplan HS. Impaired lymphocyte function in untreated Hodgkin's disease. N Engl J Med. 1974 Jan 24;290(4):181–186. [PubMed]
  • Faguet GB. Quantitation of immunocompetence in Hodgkin's disease. J Clin Invest. 1975 Oct;56(4):951–957. [PMC free article] [PubMed]
  • Ziegler JB, Hansen P, Penny R. Intrinsic lymphocyte defect in Hodgkin's disease: analysis of the phytohemagglutinin dose-response. Clin Immunol Immunopathol. 1975 Mar;3(4):451–460. [PubMed]
  • Bobrove AM, Fuks Z, Strober S, Kaplan HS. Quantitation of T and B lymphocytes and cellular immune function in Hodgkin's disease. Cancer. 1975 Jul;36(1):169–179. [PubMed]
  • Andersen E. Depletion of thymus dependent lymphocytes in Hodgkin's disease. Scand J Haematol. 1974;12(4):263–269. [PubMed]
  • Fuks Z, Strober S, Kaplan HS. Interaction between serum factors and T lymphocytes in Hodgkin's disease. Use as a diagnostic test. N Engl J Med. 1976 Dec 2;295(23):1273–1278. [PubMed]
  • Gaines JD, Gilmer MA, Remington JS. Deficiency of lymphocyte antigen recognition in Hodgkin's disease. Natl Cancer Inst Monogr. 1973 May;36:117–121. [PubMed]
  • Mendius JR, DeHoratius RJ, Messner RP, Williams RC. Family distribution of lymphocytotoxins in Hodgkin's disease. Ann Intern Med. 1976 Feb;84(2):151–156. [PubMed]
  • Goodwin JS, Messner RP, Bankhurst AD, Peake GT, Saiki JH, Williams RC., Jr Prostaglandin-producing suppressor cells in Hodgkin's disease. N Engl J Med. 1977 Nov 3;297(18):963–968. [PubMed]
  • Estevez ME, Sen L, Bachmann AE, Pavlovsky A. Defective function of peripheral blood monocytes in patients with Hodgkin's and non-Hodgkin's lymphomas. Cancer. 1980 Jul 15;46(2):299–302. [PubMed]
  • Broder S, Uchiyama T, Waldmann TA. Neoplasms of immunoregulatory cells. Am J Clin Pathol. 1979 Oct;72(4 Suppl):724–731. [PubMed]
  • Uchiyama T, Yodoi J, Sagawa K, Takatsuki K, Uchino H. Adult T-cell leukemia: clinical and hematologic features of 16 cases. Blood. 1977 Sep;50(3):481–492. [PubMed]
  • UHR JW, PAPPENHEIMER AM., Jr Delayed hypersensitivity. III. Specific desensitization of guinea pigs sensitized to protein antigens. J Exp Med. 1958 Dec 1;108(6):891–904. [PMC free article] [PubMed]
  • Dwyer JM, Kantor FS. Regulation of delayed hypersensitivity. Failure to transfer delayed hypersensitivity to desensitized guinea pigs. J Exp Med. 1973 Jan 1;137(1):32–41. [PMC free article] [PubMed]
  • Dwyer JM, Mangi RJ, Gee B, Kantor FS. Comparison of the anergy of sarcoidosis with experimentally induced anergy in guinea pigs. Ann N Y Acad Sci. 1976;278:29–35. [PubMed]
  • Schroff RW, Jr, Heise ER, Myrvik QN, Shannon BT. Selective suppression of granuloma formation and delayed hypersensitivity in rabbits. Infect Immun. 1980 Apr;28(1):269–276. [PMC free article] [PubMed]

Articles from Environmental Health Perspectives are provided here courtesy of National Institute of Environmental Health Science